Congress has voted to delay a federal ban on hemp-derived THC products that was set to take effect in November, instead giving lawmakers until December to develop regulatory frameworks that could keep these products legal. The Senate rejected an amendment that would have allowed the prohibition to proceed as scheduled, signaling growing support for regulating hemp products rather than recriminalizing them.

What Triggered the Hemp Ban Debate?

Hemp derivatives containing less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill signed by President Donald Trump during his first term. However, late last year, the president signed new legislation that would redefine hemp to allow only products with 0.4 milligrams of total THC per container to remain legal after November 12, 2026.

This dramatic shift would have effectively criminalized most hemp-derived products currently sold across the country, including hemp THC beverages, edibles, and other consumer goods. The change sparked intense debate between those who view hemp products as a public health crisis and those who argue they serve legitimate medical and wellness purposes.

How Did Congress Vote on the Delay?

On August 8, 2026, the Senate rejected an amendment from Senator Ted Budd (R-NC) that sought to keep the hemp ban on track for November. A motion to table the amendment, filed by Senator Amy Klobuchar (D-MN), passed with a vote of 61 to 32.

The underlying funding bill, which includes language to delay the hemp product ban until December 11, then passed by a vote of 90 to 6. This continuing resolution extends federal agency funding through December 11, past the end of the current fiscal year on September 30.

The legislation includes a carve-out that allows the immediate recriminalization on November 12 of synthetic cannabinoids that cannot be naturally produced by a Cannabis sativa plant, but most hemp-derived products would receive the additional time.

Who Supports and Opposes the Delay?

Support for the delay comes from an unlikely coalition of industry groups, medical advocates, and government officials. The Beverage Alcohol Merchants Coalition (BAMCO), which represents major alcohol retailers including Total Wine & More, BevMo! by Gopuff, and ABC Fine Wine & Spirits, backs the delay and is pushing Congress to establish a responsible federal framework for low-dose hemp-derived THC beverages.

Opposition to the delay is equally diverse. Senator Budd argued in a Senate floor speech that widespread availability of intoxicating hemp products represents a "public health crisis" that threatens children, harms the workforce, and undermines military readiness. His amendment garnered support from 14 cosponsors, including both Republicans and at least one Democrat.

Senator Budd

A bipartisan coalition of 35 state and territory attorneys general sent a letter calling on Congress not to reverse the hemp THC product ban, saying that lawmakers' move to enact the prohibition "protected consumers, provided much-needed regulatory clarity, and preserved legitimate industrial, agricultural, and nonintoxicating hemp markets".

What Regulatory Frameworks Are Being Proposed?

Multiple lawmakers from both chambers and both parties have filed or are circulating bills to prevent the scheduled federal recriminalization of hemp THC products. These proposals focus on creating regulations rather than outright bans. Key legislative approaches include:

• Rep. James Comer's Proposal: The House Oversight and Government Reform Committee chair is circulating legislation that would delay the planned federal ban and institute regulations including packaging requirements, testing rules, and age limits for hemp THC products.
• Rep. Andy Barr's Framework: A lengthier proposal to prevent federal recriminalization and establish regulations for manufacturing, labeling, sales, and taxation of hemp-derived products, with an age limit of 21 years old.
• BAMCO's Three-Tier System: The Beverage Alcohol Merchants Coalition supports incorporating hemp THC drinks into the existing three-tier system for alcoholic beverages, along with new requirements for testing, labeling, marketing, and taxation with flexibility for state regulations.

The White House has signaled support for regulatory approaches. Centers for Medicare and Medicaid Services Director Mehmet Oz sent a letter to senators expressing "grave concern" about the amendment that would undermine the administration's initiative to cover hemp-derived products through Medicare.

"Impaired driving is illegal and dangerous, no matter the substance. We want everyone to travel safely. If you use cannabis, please don't drive," said Saundra M. Jack, DMV Commissioner.

Saundra M. Jack, DMV Commissioner

What's the Timeline for Final Action?

The December 11 deadline gives Congress roughly four months to develop and pass comprehensive hemp regulations. White House Director of Legislative Affairs James Braid reportedly committed during a meeting with Senate Republicans that there would be no further extensions of the hemp ban's effective date if the current proposal is enacted into law.

In June, the House of Representatives passed its own version of a continuing resolution to keep federal agencies funded into December, but it did not include any provisions to alter the planned hemp product ban. The Senate's inclusion of the delay language represents a significant shift in the legislative landscape.

The debate reflects broader questions about how the federal government should approach cannabis and hemp-derived products. Rather than settling the issue through prohibition, Congress is moving toward a regulatory model that could allow these products to remain available while establishing safety standards, testing requirements, and age restrictions similar to those governing alcohol.